POST-OPERATIVE INTRAVENOUS IRON TO TREAT IRON-DEFICIENCY ANEMIA IN PATIENTS UNDERGOING CARDIAC SURGERY: A PILOT, MULTICENTRE, PLACEBO-CONTROLLED RANDOMIZED TRIAL (POAM)

Registry ID

22-5685

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

UNIVERSITY HEALTH NETWORK

Start date

2026-02-09

Last update

2022-11-24

Conditions

• IRON DEFICIENCY

Related clinical trials

• A PHASE III, RANDOMISED, OPEN-LABEL, BLINDED ENDPOINT, COMPARATIVE TRIAL OF FERRIC DERISOMALTOSE VERSUS NO INTRAVENOUS IRON IN IRON-DEFICIENT SUBJECTS WITH SYMPTOMATIC CHRONIC HEART FAILURE
• FEASIBILITY AND EFFICACY OF INTRAVENOUS FERRIC DERISOMALTOSE TO CORRECT PRE-OPERATIVE IRON-DEFICIENCY ANEMIA IN PATIENTS UNDERGOING GYNECOLOGIC ONCOLOGY SURGERY: A PILOT RANDOMIZED DOUBLE BLINDED PARALLEL GROUP PLACEBO-CONTROLLED STUDY
• INTRAVENOUS IRON ISOMALTOSIDE VERSUS IRON SUCROSE FOR TREATMENT OF IRON DEFICIENCY IN PREGNANCY: RANDOMIZED, COMPARATIVE TRIAL
• PROTOCOL TITLE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF FERRIC CARBOXYMALTOSE (US TRADE NAME: INJECTAFER) AS TREATMENT FOR HEART FAILURE WITH IRON DEFICIENCY

View on source registry